Guangyu Lyu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guangyu Lyu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Li-Jun Ning
Liuzhou Key Laboratory of Infection Disease and Immunology, Research Center of Medical Sciences, Liuzhou People’s Hospital Affiliated to Guangxi Medical University, Liuzhou, Guangxi, 545006, People’s Republic of China
1 shared publicationMei-Qiong Liu
Department of Critical Care Medicine, Liuzhou People’s Hospital Affiliated to Guangxi Medical University, Liuzhou, Guangxi, 545006, People’s Republic of China
1 shared publicationShi-Fu Tang
Department of Medical laboratory Science, Liuzhou People’s Hospital Affiliated to Guangxi Medical University, Liuzhou, Guangxi, 545006, People’s Republic of China
1 shared publicationTao Gan
Department of Emergency Medicine, Liuzhou People’s Hospital Affiliated to Guangxi Medical University, Liuzhou, Guangxi, 545006, People’s Republic of China
1 shared publicationTianbin Cai
1 shared publicationWenfang Jiang
1 shared publication
Latest Publications
- Open Access
- 1 November 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 15527-15542
Prognostic Value of C-Reactive Protein, Procalcitonin, and Interferon-Alpha in COVID-19 and Their Association with PANoptosis: A Cohort Study in Guangxi, China
Objective: Numerous biomarkers of COVID-19 severity have been studied recently, while their relevance in the post-COVID-19 era requires further validation. This study sought to identify reliable biomarkers within a single cohort through a comprehensive comparative analysis and to investigate the underlying molecular mechanisms. Material and Methods: In this prospective, observational cohort study, we comprehensively assessed 41 markers in 97 COVID-19 pneumonia patients and 53 healthy volunteers. Receiver operating characteristics and Kaplan–Meier curves were plotted to determine the predictive value of effective biomarkers. Subsequently, flow cytometry, immunofluorescence, and Western blot analysis were conducted to evaluate the inflammatory cell death induced by the identified biomarkers in peripheral blood cells. Results: Based on the screening, plasma IL-6, IL-8, IL-10, IFN-α, PCT, and CRP at hospital admission were highly associated with disease severity (P < 0.001). A pairwise combination of CRP, PCT, and IFN-α could induce PANoptosis in neutrophils, lymphocytes, and platelets. Conclusion: The value of IL-6, IL-8, IL-10, IFN-α, PCT, and CRP in predicting the severity of COVID-19 was further verified in our study, and superior to novel biomarkers. Our data confirmed for the first time that CRP, PCT, and/or IFN-α triggers PANoptosis in lymphocytes, neutrophils, and platelets, which may prompt severe progression in COVID-19 patients.
- 1 November 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 15527-15542
Open AccessPrognostic Value of C-Reactive Protein, Procalcitonin, and Interferon-Alpha in COVID-19 and Their Association with PANoptosis: A Cohort Study in Guangxi, China
Objective: Numerous biomarkers of COVID-19 severity have been studied recently, while their relevance in the post-COVID-19 era requires further validation. This study sought to identify reliable biomarkers within a single cohort through a comprehensive comparative analysis and to investigate the underlying molecular mechanisms. Material and Methods: In this prospective, observational cohort study, we comprehensively assessed 41 markers in 97 COVID-19 pneumonia patients and 53 healthy volunteers. Receiver operating characteristics and Kaplan–Meier curves were plotted to determine the predictive value of effective biomarkers. Subsequently, flow cytometry, immunofluorescence, and Western blot analysis were conducted to evaluate the inflammatory cell death induced by the identified biomarkers in peripheral blood cells. Results: Based on the screening, plasma IL-6, IL-8, IL-10, IFN-α, PCT, and CRP at hospital admission were highly associated with disease severity (P < 0.001). A pairwise combination of CRP, PCT, and IFN-α could induce PANoptosis in neutrophils, lymphocytes, and platelets. Conclusion: The value of IL-6, IL-8, IL-10, IFN-α, PCT, and CRP in predicting the severity of COVID-19 was further verified in our study, and superior to novel biomarkers. Our data confirmed for the first time that CRP, PCT, and/or IFN-α triggers PANoptosis in lymphocytes, neutrophils, and platelets, which may prompt severe progression in COVID-19 patients.